US502504A
(en)
|
|
1893-08-01 |
|
Hermann thoms |
DE487014C
(de)
|
1927-10-23 |
1929-12-09 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung von Harnstoffderivaten
|
US1792156A
(en)
*
|
1928-01-17 |
1931-02-10 |
Gen Aniline Works Inc |
5-halogen-2-amino-1-alkyloxy and 1-aralkyloxy-benzenes and intermediate products thereof and process of preparing them
|
DE511468C
(de)
|
1928-01-18 |
1930-10-30 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung von 5-Chlor-2-amino-1-methoxybenzol
|
DE523437C
(de)
|
1928-12-25 |
1931-05-05 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung von 5-Chlor- und 5-Brom-2-amino-1-alkyloxy- und 1-aralkyloxybenzolen
|
US1792158A
(en)
|
1930-04-24 |
1931-02-10 |
Robert H Gleckner |
Belt
|
US2093265A
(en)
|
1931-03-31 |
1937-09-14 |
Ici Ltd |
Process for the manufacture of diaryl ureas
|
US2046375A
(en)
|
1931-06-04 |
1936-07-07 |
Ici Ltd |
p-halogen-omicron-alkoxy-aniline derivatives and process of preparing the same
|
US2048375A
(en)
|
1935-07-06 |
1936-07-21 |
Edison Splitdorf Corp |
Magneto-electric generator
|
US2288422A
(en)
|
1938-11-11 |
1942-06-30 |
Gen Aniline & Film Corp |
Mixed ureas
|
US2973386A
(en)
*
|
1943-01-05 |
1961-02-28 |
Harry A Weldon |
Purification of sym dichloro-bis (2, 4, 6-trichlorophenyl)urea
|
DE920245C
(de)
|
1950-04-29 |
1954-11-18 |
Variapat Ag |
Verfahren zur Herstellung von aromatischen, farblosen, wasserloeslichen Trifluormethyl- und Sulfosaeuregruppen enthaltenden unsymmetrischen Harnstoffen bzw. Thioharnstoffen
|
US2683082A
(en)
|
1950-12-09 |
1954-07-06 |
Ethyl Corp |
Nu-aryl-nu'-(p-hydroxyphenyl) ureas as antioxidants for petroleum hydrocarbon fuels
|
US2722544A
(en)
|
1950-12-26 |
1955-11-01 |
Variapat Ag |
Trifluoromethyl halogenated diphenylcarbamide sulfonic acids and their preparation
|
US2781330A
(en)
*
|
1953-02-09 |
1957-02-12 |
Monsanto Chemicals |
Rubber containing urea compound as an anti-exposure cracking agent
|
BE527017A
(sl)
|
1953-03-06 |
|
|
|
US2745874A
(en)
|
1953-06-18 |
1956-05-15 |
Geigy Ag J R |
Insecticidal derivatives of diphenyl urea
|
GB771333A
(en)
|
1953-12-22 |
1957-03-27 |
Geigy Ag J R |
Improvements relating to halogen substituted diphenyl urea and thiourea compounds and their use
|
NL193403A
(sl)
*
|
1953-12-22 |
1924-02-17 |
|
|
GB828231A
(en)
|
1955-10-20 |
1960-02-17 |
Geigy Ag J R |
Improvements relating to insecticidal compounds and their use
|
US2877268A
(en)
*
|
1956-12-24 |
1959-03-10 |
Monsanto Chemicals |
Substituted ureas
|
US2960488A
(en)
|
1958-04-25 |
1960-11-15 |
Eastman Kodak Co |
Poly-alpha-olefins containing substituted ureas
|
NL254871A
(sl)
|
1959-08-14 |
|
|
|
NL277504A
(sl)
|
1961-04-21 |
|
|
|
US3177110A
(en)
*
|
1961-07-24 |
1965-04-06 |
Aschaffenburger Zellstoffwerke |
Process for pretreating wood for the production of cellulose
|
CH428747A
(de)
|
1961-09-11 |
1967-01-31 |
Wander Ag Dr A |
Verfahren zur Herstellung neuer Harnstoff- und Thioharnstoffderivate
|
US3200035A
(en)
|
1962-06-01 |
1965-08-10 |
Ciba Ltd |
Treatment of synthetic products, especially synthetic fibers
|
US3284433A
(en)
|
1963-07-17 |
1966-11-08 |
Merck & Co Inc |
4-phenoxy-carbanilides
|
FR1457172A
(fr)
|
1964-12-12 |
1966-10-28 |
Ferrania Spa |
Procédé pour la production d'images photographiques en couleurs et matériel photographique correspondant
|
FR90420E
(sl)
|
1965-06-09 |
1968-02-21 |
|
|
US3424761A
(en)
*
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
3-ureidopyrrolidines
|
US3424762A
(en)
*
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
Certain 3-ureidopyrrolidines
|
US3424760A
(en)
*
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
3-ureidopyrrolidines
|
US3743498A
(en)
|
1967-10-31 |
1973-07-03 |
Du Pont |
Method of selectively controlling undesirable vegetation
|
US3547940A
(en)
|
1967-10-31 |
1970-12-15 |
Du Pont |
Substituted ureido isoxazoles
|
SE370866B
(sl)
|
1968-03-21 |
1974-11-04 |
Ciba Geigy Ag |
|
DE1768244A1
(de)
*
|
1968-04-19 |
1971-10-14 |
Bayer Ag |
N-(2,2,4,4-Tetrafluor-1,3-benz-dioxanyl)-harnstoffe und Verfahren zu ihrer Herstellung
|
US3754887A
(en)
|
1969-05-05 |
1973-08-28 |
Du Pont |
Ureidopyrazoles defoliants
|
US3646059A
(en)
*
|
1969-05-05 |
1972-02-29 |
Du Pont |
Plant growth regulatory ureidopyrazoles
|
US3668222A
(en)
|
1969-05-14 |
1972-06-06 |
Sandoz Ltd |
11-desacetoxy-wortmannin
|
BE754782A
(fr)
|
1969-08-14 |
1971-02-12 |
May & Baker Ltd |
Derives du thiophene a action herbicide
|
US3823161A
(en)
|
1970-05-07 |
1974-07-09 |
Exxon Research Engineering Co |
Aminothiophene derivatives
|
US3860645A
(en)
*
|
1973-05-23 |
1975-01-14 |
Givaudan Corp |
Bacteriostatic substituted carbanilides
|
US4062861A
(en)
|
1973-07-27 |
1977-12-13 |
Shionogi & Co., Ltd. |
3-Isoxazolylurea derivatives
|
JPS5031039A
(sl)
|
1973-07-27 |
1975-03-27 |
|
|
US4212981A
(en)
|
1973-07-27 |
1980-07-15 |
Shionogi & Co., Ltd. |
Process for preparing 3-isoxazolylurea derivatives
|
US4116671A
(en)
|
1973-07-27 |
1978-09-26 |
Shionogi & Co., Ltd. |
3-Isoxazolylcarbamate derivatives
|
US4001256A
(en)
*
|
1973-12-26 |
1977-01-04 |
The Upjohn Company |
Pyridylalkyl phenyl ureas and their n-oxides
|
US3931201A
(en)
|
1974-01-22 |
1976-01-06 |
The Dow Chemical Company |
Substituted pyridinyloxy(thio)phenyl -acetamides, -ureas and urea derivatives
|
US4009847A
(en)
*
|
1974-04-17 |
1977-03-01 |
E. I. Du Pont De Nemours And Company |
1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents
|
US3990879A
(en)
|
1974-12-26 |
1976-11-09 |
Eli Lilly And Company |
Method of controlling aquatic weeds
|
US4111683A
(en)
|
1975-06-27 |
1978-09-05 |
Chevron Research Company |
N-alkyl or alkoxy-N'-substituted hydrocarbyl urea
|
DE2637947C2
(de)
|
1976-08-24 |
1985-09-19 |
Bayer Ag, 5090 Leverkusen |
Tetrafluor-1,3-benzodioxanyl-benzoylharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Insektizide
|
US4173637A
(en)
|
1976-10-29 |
1979-11-06 |
Ishihara Sangyo Kaisha Ltd. |
N-Benzoyl-N'-pyridyloxy phenyl urea and insecticidal compositions thereof
|
JPS5840946B2
(ja)
|
1976-10-29 |
1983-09-08 |
石原産業株式会社 |
N−ベンゾイル−n′−ピリジルオキシフエニルウレア系化合物、それらの製造方法及びそれらを含有する殺虫剤
|
US4071524A
(en)
*
|
1976-11-08 |
1978-01-31 |
Riker Laboratories, Inc. |
Derivatives of urea
|
US4183854A
(en)
*
|
1976-11-10 |
1980-01-15 |
John Wyeth & Brother Limited |
Thiazole compound
|
US4042372A
(en)
|
1976-11-19 |
1977-08-16 |
Eli Lilly And Company |
Substituted thiadiazolotriazinediones and method of preparation
|
DE2817449A1
(de)
|
1978-04-21 |
1979-10-31 |
Bayer Ag |
Mittel zur regulierung des pflanzenwachstums
|
GB1590870A
(en)
|
1978-05-31 |
1981-06-10 |
Shionogi & Co |
N-(5-t-butyl-3-isoxazolyl) alkanamide derivatives having herbicidal activity
|
JPS5562066A
(en)
|
1978-11-03 |
1980-05-10 |
Toshihiko Okamoto |
N-(2-substituted-4-pyridyl)-urea and thio urea, their preparation and plant growth regulator
|
DE2848330A1
(de)
|
1978-11-03 |
1980-05-14 |
Schering Ag |
Verfahren zur herstellung von 1,2, 3-thiadiazol-5-yl-harnstoffen
|
FI800559A
(fi)
|
1979-03-14 |
1980-09-15 |
Hoffmann La Roche |
Urinaemnederivat
|
JPS55124763A
(en)
|
1979-03-19 |
1980-09-26 |
Ishihara Sangyo Kaisha Ltd |
5-trifluoromethyl-2-pyridone derivative
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
US4468380A
(en)
|
1979-12-26 |
1984-08-28 |
Eli Lilly And Company |
Anticoccidial combinations comprising polyether antibiotics and carbanilides
|
WO1981002156A1
(en)
|
1980-01-25 |
1981-08-06 |
Reanal Finomvegyszergyar |
Process for the preparation of n-aryl-n'-(mono-or disubstiuted)-urea derivatives
|
EP0057797B1
(en)
|
1981-02-03 |
1986-06-25 |
Imperial Chemical Industries Plc |
Process for the extraction of metal values and novel metal extractants
|
US4526997A
(en)
|
1981-05-06 |
1985-07-02 |
Doherty George O P O |
Anticoccidial combinations comprising polyether antibiotics and carbanilides
|
US4511571A
(en)
*
|
1981-10-20 |
1985-04-16 |
Ciba Geigy Corporation |
N-(2-Pyridyloxyphenyl)-N'-benzoyl ureas, pesticidal compositions containing same and pesticidal methods of use
|
US4473579A
(en)
|
1982-01-26 |
1984-09-25 |
American Cyanamid Company |
Antiatherosclerotic tetrasubstituted ureas and thioureas
|
US4623662A
(en)
|
1985-05-23 |
1986-11-18 |
American Cyanamid Company |
Antiatherosclerotic ureas and thioureas
|
DE3211851A1
(de)
*
|
1982-03-31 |
1983-10-06 |
Basf Ag |
Dihydrothiophen-carbonester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
|
JPS58203957A
(ja)
*
|
1982-05-25 |
1983-11-28 |
Ube Ind Ltd |
尿素誘導体の製法
|
AU1862083A
(en)
|
1982-09-02 |
1984-03-08 |
Duphar International Research B.V. |
Tumor growth inhibitors
|
CA1254212A
(en)
*
|
1982-11-12 |
1989-05-16 |
Shiro Hirai |
Amine derivatives, salts thereof, process for preparing the same and an anti-ulcer agent containing the same
|
DE3305866A1
(de)
|
1983-02-19 |
1984-08-23 |
Basf Ag, 6700 Ludwigshafen |
Thiophen-carbonester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
|
US4499097A
(en)
*
|
1983-03-10 |
1985-02-12 |
American Cyanamid Company |
2-(Pyridyl)imidazolyl ketones
|
GB8325496D0
(en)
|
1983-09-23 |
1983-10-26 |
Hider R C |
Pharmaceutical compositions
|
US4540566A
(en)
|
1984-04-02 |
1985-09-10 |
Forest Laboratories, Inc. |
Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
|
US4727077A
(en)
|
1985-02-20 |
1988-02-23 |
Ishihara Sangyo Kaisha Ltd. |
Benzoyl urea compounds, process for their production, and antitumorous compositions containing them
|
DE3529247A1
(de)
|
1985-05-17 |
1986-11-20 |
Bayer Ag, 5090 Leverkusen |
Verwendung von thienylharnstoffen und -isoharnstoffen als leistungsfoerdernde mittel bei tieren, neue thienylharnstoffe und -isoharnstoffe und ihre herstellung
|
DE3540377A1
(de)
|
1985-11-14 |
1987-05-21 |
Bayer Ag |
Thienooxazinone, verfahren zu ihrer herstellung und ihre verwendung als leistungsfoerderer
|
DE3541631A1
(de)
*
|
1985-11-26 |
1987-05-27 |
Bayer Ag |
Selektiv-fungizide verwendung von thienylharnstoff-derivaten
|
AU594098B2
(en)
|
1985-12-11 |
1990-03-01 |
Ishihara Sangyo Kaisha Ltd. |
N-benzoyl urea compounds, antitumorous compositions containing them, and process for their preparation
|
EP0230400A3
(de)
|
1986-01-21 |
1990-02-14 |
Ciba-Geigy Ag |
N-3-(5-Trifluormethyl-pyridyl-2-oxy)-phenyl-N'-benzoylharnstoffe zur Bekämpfung von Helminthen an Nutztieren
|
JPS62185013A
(ja)
|
1986-02-08 |
1987-08-13 |
Green Cross Corp:The |
易吸収性医薬組成物
|
DE3612830A1
(de)
|
1986-04-16 |
1987-10-22 |
Basf Ag |
Thiadiazolylharnstoff enthaltendes mittel zur entblaetterung von pflanzen
|
DE3785507T2
(de)
*
|
1986-07-31 |
1993-07-29 |
Beecham Group Plc |
Azabicyclische verbindungen, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
|
NZ221964A
(en)
*
|
1986-10-03 |
1990-03-27 |
Ishihara Sangyo Kaisha |
Benzoylurea compounds and insecticidal compositions
|
EP0264904A3
(en)
|
1986-10-23 |
1988-08-17 |
Ishihara Sangyo Kaisha, Ltd. |
Pharmaceutical compositions containing benzoyl urea derivatives
|
DE3636190A1
(de)
*
|
1986-10-24 |
1988-04-28 |
Bayer Ag |
Verfahren zur herstellung von n,n-diaryl-harnstoffen
|
DD253997A1
(de)
|
1986-11-26 |
1988-02-10 |
Karl Marx Uni Buero Fuer Neuer |
Verfahren zur herstellung von substituierten 2-arylureidophenolen
|
JPH06100808B2
(ja)
|
1987-05-28 |
1994-12-12 |
富士写真フイルム株式会社 |
ハロゲン化銀カラ−写真感光材料の処理方法
|
DE3853662D1
(de)
|
1987-10-16 |
1995-06-01 |
Ciba Geigy Ag |
Schädlingsbekämpfungsmittel.
|
DE3810382A1
(de)
|
1988-03-26 |
1989-10-12 |
Bayer Ag |
5-amino-1-phenylpyrazole, verfahren sowie 5-halogen-1-phenylpyrazole als zwischenprodukte zu deren herstellung und ihre verwendung als herbizide
|
WO1990002112A1
(en)
|
1988-08-23 |
1990-03-08 |
The Nutrasweet Company |
Substituted aryl ureas as high potency sweeteners
|
EP0359146B1
(en)
|
1988-09-08 |
1994-08-03 |
Dainippon Ink And Chemicals, Inc. |
Liquid crystal device
|
JPH0278699A
(ja)
|
1988-09-12 |
1990-03-19 |
Green Cross Corp:The |
ベンゾイルウレア系化合物・アルブミン複合体
|
FR2662692B1
(fr)
|
1990-05-30 |
1995-04-28 |
Novapharme |
Derives heterocycliques doues d'activite anticonvulsivante, procede de preparation et composition pharmaceutique.
|
FR2639636B1
(fr)
|
1988-11-30 |
1994-03-04 |
Novapharme |
Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant
|
JPH02196719A
(ja)
|
1989-01-24 |
1990-08-03 |
Green Cross Corp:The |
粉末状医薬組成物
|
JPH02237922A
(ja)
|
1989-01-24 |
1990-09-20 |
Green Cross Corp:The |
抗ウィルス剤
|
EP0379915A1
(de)
|
1989-01-26 |
1990-08-01 |
Bayer Ag |
Substituierte Phenoxybenzonitril-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und Pflanzenwuchsregulatoren
|
JP3002204B2
(ja)
*
|
1989-03-13 |
2000-01-24 |
株式会社東芝 |
時系列信号認識装置
|
US4973675A
(en)
|
1989-04-13 |
1990-11-27 |
University Of Tennessee Research Center |
Hybrid nitrosoureidoanthracyclines having antitumor activity
|
JPH0395153A
(ja)
|
1989-06-15 |
1991-04-19 |
Mitsubishi Kasei Corp |
ジフェニル尿素誘導体
|
US5665543A
(en)
|
1989-07-18 |
1997-09-09 |
Oncogene Science, Inc. |
Method of discovering chemicals capable of functioning as gene expression modulators
|
IL95860A0
(en)
|
1989-10-13 |
1991-07-18 |
Ciba Geigy Ag |
Thienylthioureas,-isothioureas and-carbodiimides
|
US5177110A
(en)
*
|
1989-10-27 |
1993-01-05 |
Ciba-Geigy Corporation |
Injectable parasiticidal composition
|
EP0425443A1
(de)
|
1989-10-27 |
1991-05-02 |
Ciba-Geigy Ag |
Injizierbares parasitizides Mittel
|
KR100196559B1
(ko)
*
|
1990-06-19 |
1999-06-15 |
기따사또 이찌로 |
안지오텐신ii 길항작용을 함유하는 피리딘 유도체
|
DE4022720A1
(de)
*
|
1990-07-17 |
1992-01-23 |
Flohe Gmbh & Co |
Untergefaess eines gleichstromlichtbogenofens
|
GB9017892D0
(en)
|
1990-08-15 |
1990-09-26 |
May & Baker Ltd |
New compositions of matter
|
PT98990A
(pt)
|
1990-09-19 |
1992-08-31 |
American Home Prod |
Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
|
US5319099A
(en)
|
1991-01-21 |
1994-06-07 |
Shionogi Seiyaku Kabushiki Kaisha |
3-benzylidene-1-carbamoyl-2-pyrrolidone compounds useful as antiinflammatory agents
|
JP2671693B2
(ja)
|
1991-03-04 |
1997-10-29 |
松下電器産業株式会社 |
バイオセンサおよびその製造法
|
US5120842A
(en)
|
1991-04-01 |
1992-06-09 |
American Home Products Corporation |
Silyl ethers of rapamycin
|
US5185438A
(en)
*
|
1991-04-02 |
1993-02-09 |
The Trustees Of Princeton University |
Nucleic acids encoding hencatoporetic stem cell receptor flk-2
|
US5270458A
(en)
|
1991-04-02 |
1993-12-14 |
The Trustees Of Princeton University |
Nucleic acids encoding fragments of hematopoietic stem cell receptor flk-2
|
US5100883A
(en)
*
|
1991-04-08 |
1992-03-31 |
American Home Products Corporation |
Fluorinated esters of rapamycin
|
US5118678A
(en)
|
1991-04-17 |
1992-06-02 |
American Home Products Corporation |
Carbamates of rapamycin
|
FI921595A
(fi)
|
1991-04-17 |
1992-10-18 |
American Home Prod |
Rapamycinkarbamater
|
US5721237A
(en)
*
|
1991-05-10 |
1998-02-24 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
|
US5118677A
(en)
|
1991-05-20 |
1992-06-02 |
American Home Products Corporation |
Amide esters of rapamycin
|
US5162360A
(en)
|
1991-06-24 |
1992-11-10 |
Warner-Lambert Company |
2-heteroatom containing urea and thiourea ACAT inhibitors
|
US5185358A
(en)
*
|
1991-06-24 |
1993-02-09 |
Warner-Lambert Co. |
3-heteroatom containing urea and thiourea ACAT inhibitors
|
WO1993004170A1
(en)
*
|
1991-08-23 |
1993-03-04 |
The United States Of America Represented By The Secretary, Department Of Health And Human Services |
Raf protein kinase therapeutics
|
US5151413A
(en)
|
1991-11-06 |
1992-09-29 |
American Home Products Corporation |
Rapamycin acetals as immunosuppressant and antifungal agents
|
WO1993018028A1
(en)
|
1992-03-12 |
1993-09-16 |
Smithkline Beecham Plc |
Indole derivatives as 5ht1c antagonists
|
JPH07503737A
(ja)
|
1992-05-28 |
1995-04-20 |
フアイザー・インコーポレイテツド |
アシル補酵素a:コレステロールアシルトランスフェラーゼ(acat)の阻害剤としての新規なn−アリールおよびn−ヘテロアリール尿素誘導体
|
JPH0625221A
(ja)
|
1992-07-10 |
1994-02-01 |
Tokuyama Soda Co Ltd |
3−アミノ−2−チオフェンカルボン酸誘導体の製造方法
|
US5312820A
(en)
|
1992-07-17 |
1994-05-17 |
Merck & Co., Inc. |
Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines
|
ZA935112B
(en)
|
1992-07-17 |
1994-02-08 |
Smithkline Beecham Corp |
Rapamycin derivatives
|
ZA935111B
(en)
|
1992-07-17 |
1994-02-04 |
Smithkline Beecham Corp |
Rapamycin derivatives
|
KR950702994A
(ko)
|
1992-08-12 |
1995-08-23 |
로렌스 티. 웰츠 |
탁솔과 복합된, 단백질 키나제 억제제 및 관련 화합물(protein kinase inhibitors and related compounds combined with taxol)
|
US5256790A
(en)
|
1992-08-13 |
1993-10-26 |
American Home Products Corporation |
27-hydroxyrapamycin and derivatives thereof
|
DE4227989A1
(de)
|
1992-08-21 |
1994-06-09 |
Schering Ag |
Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
|
JP2717481B2
(ja)
|
1992-08-25 |
1998-02-18 |
富士写真フイルム株式会社 |
ハロゲン化銀カラー写真感光材料
|
CN2146707Y
(zh)
|
1992-09-08 |
1993-11-17 |
华东冶金学院 |
高炉软水冷却***检漏装置
|
US5258389A
(en)
|
1992-11-09 |
1993-11-02 |
Merck & Co., Inc. |
O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
|
US6177401B1
(en)
*
|
1992-11-13 |
2001-01-23 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften |
Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
|
CN2148707Y
(zh)
|
1992-12-15 |
1993-12-08 |
高英郎 |
螺丝固定的雨刷的接头改进装置
|
WO1994014801A1
(en)
|
1992-12-29 |
1994-07-07 |
Smithkline Beecham Plc |
Heterocyclic urea derivatives as 5ht2c and 5ht2b antagonists
|
US5512473A
(en)
|
1993-01-29 |
1996-04-30 |
Brent; Roger |
Max-interacting proteins and related molecules and methods
|
GB9302275D0
(en)
|
1993-02-05 |
1993-03-24 |
Smithkline Beecham Plc |
Novel compounds
|
TW272942B
(sl)
|
1993-02-10 |
1996-03-21 |
Takeda Pharm Industry Co Ltd |
|
DK41193D0
(da)
|
1993-04-07 |
1993-04-07 |
Neurosearch As |
Ionkanalaabnere
|
WO1994023755A1
(en)
|
1993-04-09 |
1994-10-27 |
Board Of Regents Of The University Of Nebraska |
Novel methods and compositions for the treatment of ras-activated cancer with heterotypic anti-raf antisense oligonucleotides
|
GB9308802D0
(en)
|
1993-04-28 |
1993-06-09 |
Smithkline Beecham Plc |
Treatment
|
DE4322806A1
(de)
|
1993-07-08 |
1995-01-12 |
Janich Gmbh & Co |
Vorrichtung zur Abdichtung zwischen zwei Anlagenteilen
|
IL110296A
(en)
|
1993-07-16 |
1999-12-31 |
Smithkline Beecham Corp |
Imidazole compounds process for their preparation and pharmaceutical compositions containing them
|
US6514745B1
(en)
*
|
1993-07-19 |
2003-02-04 |
The Regents Of The University Of California |
Oncoprotein protein kinase
|
US5378725A
(en)
*
|
1993-07-19 |
1995-01-03 |
The Arizona Board Of Regents |
Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof
|
NZ264063A
(en)
*
|
1993-08-13 |
1995-11-27 |
Nihon Nohyaku Co Ltd |
N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
|
US5468773A
(en)
|
1993-08-25 |
1995-11-21 |
Eli Lilly And Company |
Methods for inhibiting bone loss and cartilage degradation using wortmannin and its analogs
|
US5441947A
(en)
|
1993-08-25 |
1995-08-15 |
Eli Lilly And Company |
Methods of inhibiting vascular restenosis
|
DK0724588T3
(da)
|
1993-09-17 |
2000-05-15 |
Smithkline Beecham Corp |
Lægemiddelbindende protein
|
US6361773B1
(en)
*
|
1993-09-17 |
2002-03-26 |
Smithkline Beecham Corporation |
Antibodies produced against cytokine suppressive anti-inflammatory drug binding proteins
|
US5869043A
(en)
*
|
1993-09-17 |
1999-02-09 |
Smithkline Beecham Corporation |
Drug binding protein
|
US5783664A
(en)
|
1993-09-17 |
1998-07-21 |
Smithkline Beecham Corporation |
Cytokine suppressive anit-inflammatory drug binding proteins
|
US5547966A
(en)
|
1993-10-07 |
1996-08-20 |
Bristol-Myers Squibb Company |
Aryl urea and related compounds
|
CA2133815A1
(en)
*
|
1993-10-12 |
1995-04-13 |
Jeffrey Alan Dodge |
Inhibition of phosphatidylinositol 3-kinase with viridin, demethoxyviridin, viridiol, demethoxyviridiol, virone, wortmannolone, and analogs thereof
|
US5596001A
(en)
*
|
1993-10-25 |
1997-01-21 |
Pfizer Inc. |
4-aryl-3-(heteroarylureido)quinoline derivatves
|
DE69433501T2
(de)
|
1993-11-08 |
2004-11-04 |
Smithkline Beecham Corp. |
Oxazole zur behandlung von zytokinvermittelten erkrankungen
|
JPH07141053A
(ja)
|
1993-11-17 |
1995-06-02 |
Nec Niigata Ltd |
クロック発生回路
|
CA2175215C
(en)
|
1993-11-19 |
2008-06-03 |
Yat Sun Or |
Semisynthetic analogs of rapamycin (macrolides) being immunomodulators
|
SK78196A3
(en)
|
1993-12-17 |
1997-02-05 |
Sandoz Ag |
Rapamycin demethoxy-derivatives, preparation method thereof and pharmaceutical agent containing them
|
US5700823A
(en)
|
1994-01-07 |
1997-12-23 |
Sugen, Inc. |
Treatment of platelet derived growth factor related disorders such as cancers
|
CH686211A5
(de)
|
1994-01-27 |
1996-02-15 |
Ciba Geigy Ag |
Motten- und Koferschutzmittel.
|
US6524832B1
(en)
*
|
1994-02-04 |
2003-02-25 |
Arch Development Corporation |
DNA damaging agents in combination with tyrosine kinase inhibitors
|
US6811779B2
(en)
|
1994-02-10 |
2004-11-02 |
Imclone Systems Incorporated |
Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
|
CA2146495C
(en)
*
|
1994-04-08 |
2006-06-27 |
Len C. Decandia |
Method for making an elastic adhesive bandage
|
DE4412334A1
(de)
|
1994-04-11 |
1995-10-19 |
Hoechst Ag |
Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
US5559137A
(en)
|
1994-05-16 |
1996-09-24 |
Smithkline Beecham Corp. |
Compounds
|
US5656612A
(en)
|
1994-05-31 |
1997-08-12 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
US5744362A
(en)
|
1994-05-31 |
1998-04-28 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
US5447957A
(en)
|
1994-06-02 |
1995-09-05 |
Smithkline Beecham Corp. |
Anti-inflammatory compounds
|
US5470882A
(en)
|
1994-06-02 |
1995-11-28 |
Smithkline Beecham Corp. |
Anti-inflammatory compounds
|
WO1995033458A1
(en)
|
1994-06-02 |
1995-12-14 |
Smithkline Beecham Corporation |
Anti-inflammatory compounds
|
US5786362A
(en)
|
1994-06-16 |
1998-07-28 |
University Of Miami |
Method of treating Hormone independent cancer
|
EP0690344A1
(en)
|
1994-06-29 |
1996-01-03 |
Konica Corporation |
Silver halide color photographic light-sensitive material
|
US5480906A
(en)
*
|
1994-07-01 |
1996-01-02 |
Eli Lilly And Company |
Stereochemical Wortmannin derivatives
|
FR2722319B1
(fr)
|
1994-07-08 |
1996-08-14 |
Thomson Csf |
Dispositif de visualisation couleurs
|
US5597719A
(en)
*
|
1994-07-14 |
1997-01-28 |
Onyx Pharmaceuticals, Inc. |
Interaction of RAF-1 and 14-3-3 proteins
|
AU3577995A
(en)
|
1994-10-04 |
1996-04-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Urea derivatives and their use as acat-inhibitors
|
DK0708085T3
(da)
|
1994-10-19 |
2002-11-11 |
Novartis Ag |
Antivirale ethere af aspartatproteasesubstrat-isostere
|
CA2161376C
(en)
*
|
1994-10-27 |
2005-01-11 |
Toshiaki Minami |
Reversible multi-color thermal recording medium
|
JP3591938B2
(ja)
|
1994-10-27 |
2004-11-24 |
キヤノン株式会社 |
インクジェット用記録媒体及びこれを用いた画像形成方法
|
WO1996013632A1
(en)
|
1994-10-28 |
1996-05-09 |
Novo Nordisk A/S |
A process for chemical finishing of insoluble polymers
|
TW313568B
(sl)
|
1994-12-20 |
1997-08-21 |
Hoffmann La Roche |
|
US5780483A
(en)
|
1995-02-17 |
1998-07-14 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
EP0809492A4
(en)
|
1995-02-17 |
2007-01-24 |
Smithkline Beecham Corp |
IL-8 RECEPTOR ANTAGONISTS
|
US5814646A
(en)
|
1995-03-02 |
1998-09-29 |
Eli Lilly And Company |
Inhibitors of amyloid beta-protein production
|
US5624937A
(en)
*
|
1995-03-02 |
1997-04-29 |
Eli Lilly And Company |
Chemical compounds as inhibitors of amyloid beta protein production
|
DE19512639A1
(de)
|
1995-04-05 |
1996-10-10 |
Merck Patent Gmbh |
Benzonitrile und -fluoride
|
FR2733324B1
(fr)
|
1995-04-19 |
1997-05-30 |
Schlumberger Ind Sa |
Procede et equipement de test automatique en parallele de composants electroniques
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
US5773459A
(en)
|
1995-06-07 |
1998-06-30 |
Sugen, Inc. |
Urea- and thiourea-type compounds
|
US5658903A
(en)
|
1995-06-07 |
1997-08-19 |
Smithkline Beecham Corporation |
Imidazole compounds, compositions and use
|
US5710173A
(en)
|
1995-06-07 |
1998-01-20 |
Sugen, Inc. |
Thienyl compounds for inhibition of cell proliferative disorders
|
ES2187660T3
(es)
|
1995-06-09 |
2003-06-16 |
Novartis Ag |
Derivados de rapamicina.
|
GB9514265D0
(en)
|
1995-07-13 |
1995-09-13 |
Wellcome Found |
Hetrocyclic compounds
|
US5849761A
(en)
|
1995-09-12 |
1998-12-15 |
Regents Of The University Of California |
Peripherally active anti-hyperalgesic opiates
|
AU712467B2
(en)
*
|
1995-09-18 |
1999-11-04 |
Sankyo Company Limited |
New urea derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use
|
SE510846C2
(sv)
|
1995-11-06 |
1999-06-28 |
Moelnlycke Health Care Ab |
Innerförpackning för i en yttre förpackning sterilförpackade bukdukar
|
US6143764A
(en)
|
1995-11-07 |
2000-11-07 |
Kirin Beer Kabushiki Kaisha |
Quinoline and quinazoline derivatives inhibiting platelet-derived growth factor receptor autophosphorylation and pharmaceutical compositions containing the same
|
JP3844782B2
(ja)
*
|
1995-12-28 |
2006-11-15 |
株式会社クレハ |
新規なn―(無置換または置換)―4―置換―6―(無置換または置換)フェノキシ―2―ピリジンカルボキサミド又はチオカルボキサミド、その製造方法および除草剤
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
US6005008A
(en)
|
1996-02-16 |
1999-12-21 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
US6011029A
(en)
|
1996-02-26 |
2000-01-04 |
Bristol-Myers Squibb Company |
Inhibitors of farnesyl protein transferase
|
US6103692A
(en)
|
1996-03-12 |
2000-08-15 |
The General Hospital Corporation |
Inhibiting protein interactions
|
US6211373B1
(en)
|
1996-03-20 |
2001-04-03 |
Smithkline Beecham Corporation |
Phenyl urea antagonists of the IL-8 receptor
|
US6262113B1
(en)
|
1996-03-20 |
2001-07-17 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
ATE189814T1
(de)
|
1996-04-15 |
2000-03-15 |
Takeda Chemical Industries Ltd |
Hydroxypyridin-derivate, ihre herstellung und ihre pharmazeutische verwendung
|
IL126674A
(en)
|
1996-04-23 |
2005-08-31 |
Vertex Pharma |
Use of cyclic and heterocyclic compounds for preparing pharmaceutical compositions inhibiting impdh activity, pharmaceutical compositions containing the same and novel thiazole and oxazole urea derivatives
|
US6232299B1
(en)
|
1996-05-01 |
2001-05-15 |
Eli Lilly And Company |
Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
|
JPH09301858A
(ja)
|
1996-05-13 |
1997-11-25 |
Senju Pharmaceut Co Ltd |
グルコン酸クロルヘキシジン安定化水性薬剤
|
EP0906273B1
(en)
|
1996-05-24 |
2002-10-16 |
Neurosearch A/S |
Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
|
US5910417A
(en)
|
1996-05-31 |
1999-06-08 |
National Jewish Center For Immunology And Respiratory Medicine |
Regulation of cytokine production in a hematopoietic cell
|
US6218539B1
(en)
|
1996-06-27 |
2001-04-17 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
WO1997049399A1
(en)
|
1996-06-27 |
1997-12-31 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
IL127667A0
(en)
|
1996-06-27 |
1999-10-28 |
Smithkline Beecham Corp |
IL-8 receptor antagonists
|
KR20000022274A
(ko)
|
1996-06-27 |
2000-04-25 |
스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 |
Il-8 수용체 길항제
|
US6150415A
(en)
|
1996-08-13 |
2000-11-21 |
The Regents Of The University Of California |
Epoxide hydrolase complexes and methods therewith
|
US5808080A
(en)
|
1996-09-05 |
1998-09-15 |
Eli Lilly And Company |
Selective β3 adrenergic agonists
|
US6019793A
(en)
|
1996-10-21 |
2000-02-01 |
Synthes |
Surgical prosthetic device
|
US5965573A
(en)
|
1996-10-23 |
1999-10-12 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
WO1998017267A1
(en)
|
1996-10-23 |
1998-04-30 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
CA2271693C
(en)
|
1996-11-15 |
2009-01-20 |
The Picower Institute For Medical Research |
Guanylhydrazones useful for treating diseases associated with t cell activation
|
GB9623833D0
(en)
|
1996-11-16 |
1997-01-08 |
Zeneca Ltd |
Chemical compound
|
WO1998022432A1
(fr)
|
1996-11-18 |
1998-05-28 |
Yamanouchi Pharmaceutical Co., Ltd. |
Derives d'acylanilide a substitution acylamino ou composition comprenant ces derives
|
FR2755967B1
(fr)
*
|
1996-11-21 |
1999-01-29 |
Pf Medicament |
Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments
|
US5929250A
(en)
*
|
1997-01-23 |
1999-07-27 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
CN1217660C
(zh)
|
1997-01-23 |
2005-09-07 |
史密丝克莱恩比彻姆公司 |
Il-8受体拮抗剂
|
CA2280048A1
(en)
|
1997-02-12 |
1998-08-13 |
Katherine L. Widdowson |
Il-8 receptor antagonists
|
TR199902432T2
(xx)
|
1997-04-04 |
2000-01-21 |
Prizer Products Inc. |
Nikotinamid t�revleri.
|
US20020111495A1
(en)
|
1997-04-04 |
2002-08-15 |
Pfizer Inc. |
Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
|
US5958983A
(en)
|
1997-04-10 |
1999-09-28 |
Pharmacia & Upjohn Company |
Polyaromatic antiviral compositions
|
WO1998049150A1
(en)
|
1997-04-25 |
1998-11-05 |
Takeda Chemical Industries, Ltd. |
Triazine derivatives, their production and agrochemical composition
|
US6210710B1
(en)
*
|
1997-04-28 |
2001-04-03 |
Hercules Incorporated |
Sustained release polymer blend for pharmaceutical applications
|
AR012634A1
(es)
*
|
1997-05-02 |
2000-11-08 |
Sugen Inc |
Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
|
US6316479B1
(en)
|
1997-05-19 |
2001-11-13 |
Sugen, Inc. |
Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
|
BR9809451A
(pt)
|
1997-05-22 |
2000-06-20 |
Searle & Co |
Pirazóis substituìdos com 3(5)-heteroarila como inibidores de quinase p38.
|
US6514977B1
(en)
|
1997-05-22 |
2003-02-04 |
G.D. Searle & Company |
Substituted pyrazoles as p38 kinase inhibitors
|
JP2002502380A
(ja)
|
1997-05-22 |
2002-01-22 |
ジー.ディー.サール アンド カンパニー |
p38キナーゼ阻害剤としてのピラゾール誘導体
|
DE1019040T1
(de)
|
1997-05-23 |
2001-02-08 |
Bayer Ag |
Hemmung von p38 kinase aktivität durch arylharnstoff
|
US6187799B1
(en)
|
1997-05-23 |
2001-02-13 |
Onyx Pharmaceuticals |
Inhibition of raf kinase activity using aryl ureas
|
US6344476B1
(en)
|
1997-05-23 |
2002-02-05 |
Bayer Corporation |
Inhibition of p38 kinase activity by aryl ureas
|
CA2291065C
(en)
|
1997-05-23 |
2010-02-09 |
Bayer Corporation |
Raf kinase inhibitors
|
US6150395A
(en)
|
1997-05-30 |
2000-11-21 |
The Regents Of The University Of California |
Indole-3-carbinol (I3C) derivatives and methods
|
US6294350B1
(en)
|
1997-06-05 |
2001-09-25 |
Dalhousie University |
Methods for treating fibroproliferative diseases
|
US5985592A
(en)
*
|
1997-06-05 |
1999-11-16 |
Dalhousie University |
Uses for pentoxifylline or functional derivatives/metabolites thereof
|
EP1023066A4
(en)
|
1997-06-13 |
2001-05-23 |
Smithkline Beecham Corp |
NEW PYRAZOLE AND PYRAZOLINE SUBSTITUTED COMPOUND
|
US6159901A
(en)
|
1997-06-27 |
2000-12-12 |
Kureha Kagaku Kogyo Kabushiki Kaisha |
6-phenoxy picolinic acid alkylidene hydrazide derivative, process for producing the same and herbicide using the same
|
US6093742A
(en)
|
1997-06-27 |
2000-07-25 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of p38
|
US6525065B1
(en)
*
|
1997-06-30 |
2003-02-25 |
Targacept, Inc. |
Pharmaceutical compositions and methods for effecting dopamine release
|
AUPP003197A0
(en)
|
1997-09-03 |
1997-11-20 |
Fujisawa Pharmaceutical Co., Ltd. |
New heterocyclic compounds
|
UA71555C2
(en)
*
|
1997-10-06 |
2004-12-15 |
Zentaris Gmbh |
Methods for modulating function of serine/threonine protein kinases by 5-azaquinoline derivatives
|
AU9802198A
(en)
|
1997-10-21 |
1999-05-10 |
Pharmacia & Upjohn Company |
Antiinflammatory thiadiazolyl ureas which act as lfa-1 and mac-1 inhibitors
|
KR20010031557A
(ko)
|
1997-10-31 |
2001-04-16 |
추후제출 |
치환 아닐리드
|
CA2308428A1
(en)
|
1997-11-03 |
1999-05-14 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as anti-inflammatory agents
|
US6022884A
(en)
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
WO1999024035A1
(en)
|
1997-11-10 |
1999-05-20 |
Bristol-Myers Squibb Company |
Benzothiazole protein tyrosine kinase inhibitors
|
US6018065A
(en)
|
1997-11-10 |
2000-01-25 |
Advanced Technology Materials, Inc. |
Method of fabricating iridium-based materials and structures on substrates, iridium source reagents therefor
|
GB9723789D0
(en)
|
1997-11-12 |
1998-01-07 |
Zeneca Ltd |
Chemical compounds
|
WO1999026657A1
(en)
*
|
1997-11-25 |
1999-06-03 |
Musc Foundation For Research Development |
Inhibitors of nitric oxide synthase
|
WO1999028305A1
(en)
|
1997-12-01 |
1999-06-10 |
E.I. Du Pont De Nemours And Company |
Fungicidal cyclic amides
|
US6635421B1
(en)
|
1997-12-09 |
2003-10-21 |
Children's Medical Center Corporation |
Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
|
SK282727B6
(sk)
|
1997-12-19 |
2002-11-06 |
Slovakofarma, A. S. |
1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy
|
US6174901B1
(en)
*
|
1998-12-18 |
2001-01-16 |
Amgen Inc. |
Substituted pyridine and pyridazine compounds and methods of use
|
ID26620A
(id)
*
|
1997-12-22 |
2001-01-25 |
Bayer Ag |
Penghambatan kinase raf yang menggunakan urea-urea heterosiklik yang disubstitusi
|
US20080300281A1
(en)
|
1997-12-22 |
2008-12-04 |
Jacques Dumas |
Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
|
US7329670B1
(en)
*
|
1997-12-22 |
2008-02-12 |
Bayer Pharmaceuticals Corporation |
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
|
DK1043995T3
(da)
|
1997-12-22 |
2007-03-05 |
Bayer Pharmaceuticals Corp |
Inhibering af p38 kinaseaktivitet ved anvendelse af aryl- og heteroaryl-substituerede, heterocykliske urinstoffer
|
US7517880B2
(en)
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
SK286564B6
(sk)
|
1997-12-22 |
2009-01-07 |
Bayer Corporation |
Substituované arylmočoviny ako inhibítory rafkinázy a farmaceutický prípravok s ich obsahom
|
MXPA00006233A
(es)
*
|
1997-12-22 |
2002-09-18 |
Bayer Ag |
Inhibicion de la actividad de la cinasa p38 utilizando ureas heterociclicas sustituidas.
|
US20070244120A1
(en)
|
2000-08-18 |
2007-10-18 |
Jacques Dumas |
Inhibition of raf kinase using substituted heterocyclic ureas
|
ATE297383T1
(de)
|
1997-12-22 |
2005-06-15 |
Bayer Pharmaceuticals Corp |
Hemmung der p38 kinase unter verwendung von symmetrischen und asymmetrischen diphenylharnstoffen
|
BR9814361A
(pt)
*
|
1997-12-22 |
2001-11-27 |
Bayer Ag |
Inibição de quinase raf usando uréiasheterocìclicas substituìdas por arila eheteroarila
|
WO1999032109A1
(en)
|
1997-12-23 |
1999-07-01 |
Bristol-Myers Squibb Company |
7-deoxy-6-nitrogen substituted paclitaxels
|
AU1689999A
(en)
|
1997-12-25 |
1999-07-19 |
Daiichi Pharmaceutical Co., Ltd. |
Medicinal composition for percutaneous administration
|
GB9800575D0
(en)
|
1998-01-12 |
1998-03-11 |
Glaxo Group Ltd |
Heterocyclic compounds
|
WO1999037604A2
(en)
|
1998-01-21 |
1999-07-29 |
Zymogenetics, Inc. |
Dialkyl ureas as calcitonin mimetics
|
FR2774824B1
(fr)
|
1998-02-09 |
2000-04-28 |
Moving Magnet Tech |
Actionneur lineaire ameliore
|
ATE238553T1
(de)
*
|
1998-02-18 |
2003-05-15 |
Theryte Ltd |
Krebsbehandlung
|
MY132496A
(en)
|
1998-05-11 |
2007-10-31 |
Vertex Pharma |
Inhibitors of p38
|
US6413773B1
(en)
*
|
1998-06-01 |
2002-07-02 |
The Regents Of The University Of California |
Phosphatidylinositol 3-kinase inhibitors as stimulators of endocrine differentiation
|
UA60365C2
(uk)
|
1998-06-04 |
2003-10-15 |
Пфайзер Продактс Інк. |
Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
|
US6667340B1
(en)
|
1998-06-26 |
2003-12-23 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Inhibitors of phosphatidyl myo-inositol cycle
|
US6352977B1
(en)
*
|
1998-07-13 |
2002-03-05 |
Aventis Pharma Limited |
Substituted β-alanines
|
US6184226B1
(en)
|
1998-08-28 |
2001-02-06 |
Scios Inc. |
Quinazoline derivatives as inhibitors of P-38 α
|
EP1114039A1
(en)
|
1998-09-18 |
2001-07-11 |
Vertex Pharmaceuticals Incorporated |
INHIBITORS OF p38
|
US6383734B1
(en)
|
1998-09-30 |
2002-05-07 |
Advanced Research And Technology Institute, Inc. |
Method to determine inhibition of PAK3 activation of Raf-1
|
US6130053A
(en)
|
1999-08-03 |
2000-10-10 |
Cell Pathways, Inc. |
Method for selecting compounds for inhibition of neoplastic lesions
|
GB9823873D0
(en)
|
1998-10-30 |
1998-12-30 |
Pharmacia & Upjohn Spa |
2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
|
IL142583A0
(en)
|
1998-11-06 |
2002-03-10 |
Basf Ag |
Inhibition of the formation of vascular hyperpermeability
|
WO2000031238A2
(en)
|
1998-11-25 |
2000-06-02 |
Genetica, Inc. |
Methods and reagents for increasing proliferative capacity and preventing replicative senescence
|
US6114517A
(en)
|
1998-12-10 |
2000-09-05 |
Isis Pharmaceuticals Inc. |
Methods of modulating tumor necrosis factor α-induced expression of cell adhesion molecules
|
WO2000035455A1
(en)
|
1998-12-15 |
2000-06-22 |
Telik, Inc. |
Heteroaryl-aryl ureas as igf-1 receptor antagonists
|
UY25842A1
(es)
|
1998-12-16 |
2001-04-30 |
Smithkline Beecham Corp |
Antagonistas de receptores de il-8
|
US6492400B1
(en)
|
1998-12-18 |
2002-12-10 |
Bristol-Myers Squibb Pharma Company |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
US6331541B1
(en)
*
|
1998-12-18 |
2001-12-18 |
Soo S. Ko |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
US6147107A
(en)
|
1998-12-20 |
2000-11-14 |
Virginia Commonwealth University |
Specific inhibition of the P42/44 mitogen activated protein (map) kinase cascade sensitizes tumor cells
|
US20080269265A1
(en)
|
1998-12-22 |
2008-10-30 |
Scott Miller |
Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
|
GB9828511D0
(en)
|
1998-12-24 |
1999-02-17 |
Zeneca Ltd |
Chemical compounds
|
CN1326848C
(zh)
|
1998-12-25 |
2007-07-18 |
帝国脏器制药株式会社 |
氨基吡唑衍生物
|
US20020065296A1
(en)
|
1999-01-13 |
2002-05-30 |
Bayer Corporation |
Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
|
WO2000042012A1
(en)
|
1999-01-13 |
2000-07-20 |
Bayer Corporation |
φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
|
ATE556713T1
(de)
|
1999-01-13 |
2012-05-15 |
Bayer Healthcare Llc |
Omega-carboxyarylsubstituierte-diphenyl- harnstoffe als p38-kinasehemmer
|
ME00275B
(me)
|
1999-01-13 |
2011-02-10 |
Bayer Corp |
ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE
|
US7928239B2
(en)
|
1999-01-13 |
2011-04-19 |
Bayer Healthcare Llc |
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
TWI284642B
(en)
|
1999-01-18 |
2007-08-01 |
Hoffmann La Roche |
Novel heterocyclic sulfonamides
|
UA73492C2
(en)
|
1999-01-19 |
2005-08-15 |
|
Aromatic heterocyclic compounds as antiinflammatory agents
|
KR100787254B1
(ko)
|
1999-01-22 |
2007-12-20 |
기린 홀딩스 가부시키가이샤 |
퀴놀린유도체 및 퀴나졸린유도체
|
ATE274512T1
(de)
|
1999-02-12 |
2004-09-15 |
Smithkline Beecham Plc |
Phenylharnstoffe und phenylthioharnstoffe als orexinrezeptorantagonisten
|
CA2360934A1
(en)
|
1999-02-22 |
2000-08-31 |
Lin-Hua Zhang |
Polycyclo heterocyclic derivatives as antiinflammatory agents
|
ES2251360T3
(es)
|
1999-03-12 |
2006-05-01 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Compuestos heterociclicos aromaticos en calidad de agentes antiinflamatorios.
|
ID30176A
(id)
|
1999-03-12 |
2001-11-08 |
Boehringer Ingelheim Pharma |
Senyawa-senyawa yang bermanfaat sebagai zat anti-inflamasi
|
JP4184610B2
(ja)
|
1999-03-19 |
2008-11-19 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Impdh酵素のインヒビター
|
NZ514756A
(en)
|
1999-03-26 |
2004-04-30 |
Euro Celtique S |
Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
|
US6140124A
(en)
|
1999-04-06 |
2000-10-31 |
Isis Pharmaceuticals Inc. |
Antisense modulation of P38 mitogen activated protein kinase expression
|
US6316462B1
(en)
|
1999-04-09 |
2001-11-13 |
Schering Corporation |
Methods of inducing cancer cell death and tumor regression
|
ES2218156T3
(es)
|
1999-05-05 |
2004-11-16 |
Aventis Pharma Limited |
Ureas y su uso como moduladores de la adhesion celular.
|
AU782994C
(en)
|
1999-05-14 |
2006-08-24 |
Imclone Llc |
Treatment of refractory human tumors with epidermal growth factor receptor antagonists
|
HN2000000051A
(es)
|
1999-05-19 |
2001-02-02 |
Pfizer Prod Inc |
Derivados heterociclicos utiles como agentes anticancerosos
|
TWI234557B
(en)
|
1999-05-26 |
2005-06-21 |
Telik Inc |
Novel naphthalene ureas as glucose uptake enhancers
|
DE19927835A1
(de)
|
1999-06-18 |
2000-12-21 |
Clariant Gmbh |
Verwendung von verbesserten Cyanpigmenten in elektrophotographischen Tonern und Entwicklern, Pulverlacken und Ink-Jet-Tinten
|
MXPA02000314A
(es)
|
1999-07-09 |
2004-06-22 |
Boehringer Ingelheim Pharma |
Proceso novedoso para la sintesis de compuestos de urea substituidos con heteroarilo.
|
EP1199306B1
(en)
|
1999-07-26 |
2005-12-07 |
Banyu Pharmaceutical Co., Ltd. |
Biarylurea derivatives
|
ATE321751T1
(de)
|
1999-07-28 |
2006-04-15 |
Kirin Brewery |
Harnstoffderivate als ccr-3 rezeptor-inhibitoren
|
US6387900B1
(en)
|
1999-08-12 |
2002-05-14 |
Pharmacia & Upjohn S.P.A. |
3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents
|
US6372933B1
(en)
|
1999-08-26 |
2002-04-16 |
Smithkline Beecham Corporation |
Process for preparing certain phenyl urea compounds
|
US6420378B1
(en)
|
1999-10-15 |
2002-07-16 |
Supergen, Inc. |
Inhibition of abnormal cell proliferation with camptothecin and combinations including the same
|
EP1220688A1
(en)
|
1999-10-15 |
2002-07-10 |
The van Kampen Group, Inc. |
Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes
|
US6794393B1
(en)
|
1999-10-19 |
2004-09-21 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
CA2389360C
(en)
|
1999-11-16 |
2008-06-03 |
Steffen Breitfelder |
Urea derivatives as anti-inflammatory agents
|
AU2464601A
(en)
|
1999-12-29 |
2001-07-09 |
Wyeth |
Tricyclic protein kinase inhibitors
|
US6525046B1
(en)
*
|
2000-01-18 |
2003-02-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as antiinflammatory agents
|
US7740841B1
(en)
|
2000-01-28 |
2010-06-22 |
Sunnybrook Health Science Center |
Therapeutic method for reducing angiogenesis
|
JP2003521543A
(ja)
|
2000-02-07 |
2003-07-15 |
アボット ゲーエムベーハー ウント カンパニー カーゲー |
2−ベンゾチアゾリル尿素誘導体およびそのプロテインキナーゼ阻害剤としての使用
|
US6608052B2
(en)
|
2000-02-16 |
2003-08-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
US6658473B1
(en)
|
2000-02-25 |
2003-12-02 |
Sun Microsystems, Inc. |
Method and apparatus for distributing load in a computer environment
|
AU4194601A
(en)
|
2000-03-02 |
2001-09-12 |
Ludwig Institute For Cancer Research |
Methods for treating, screening for, and detecting cancers expressing vascular endothelial growth factor
|
GB0005357D0
(en)
|
2000-03-06 |
2000-04-26 |
Smithkline Beecham Plc |
Compounds
|
US7498335B2
(en)
|
2000-03-06 |
2009-03-03 |
Astrazeneca Ab |
Method of producing an antiangiogenic or vascular permeability reducing effect
|
WO2001072751A1
(en)
*
|
2000-03-29 |
2001-10-04 |
Knoll Gesellschaft Mit Beschraenkter Haftung |
Pyrrolopyrimidines as tyrosine kinase inhibitors
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
US6403588B1
(en)
|
2000-04-27 |
2002-06-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Imidazopyridine derivatives
|
FR2811670B1
(fr)
|
2000-07-13 |
2004-05-14 |
Rhodia Chimie Sa |
Stabilisation de compositions polymeriques, organosiliciques ou silicone
|
US6390102B1
(en)
|
2000-07-14 |
2002-05-21 |
General Electric Company |
Silicone compositions for personal care products and method for making
|
WO2002007747A1
(en)
|
2000-07-18 |
2002-01-31 |
Joslin Diabetes Center, Inc. |
Methods of modulating fibrosis
|
MXPA02012909A
(es)
|
2000-07-24 |
2004-05-05 |
Boehringer Ingelheim Pharma |
Formulaciones mejoradas de dosis oral de 1-(5-ter-butil -2-p-tiolil2h -pirazol-3 -il)-3-(4-2 (2-morfolin-4-il -etoxi) -naftalen -1-il) -urea.
|
GT200100147A
(es)
|
2000-07-31 |
2002-06-25 |
|
Derivados de imidazol
|
MXPA03000937A
(es)
|
2000-08-04 |
2004-08-02 |
Univ Loma Linda Med |
Proteina reguladora del hierro (irp-2) como un diagnostico para enfermedades neurodegenerativas.
|
CA2418389A1
(en)
|
2000-08-11 |
2002-02-21 |
Vertex Pharmaceuticals Incorporated |
Pyridine derivatives as inhibitors of p38
|
US20020173507A1
(en)
|
2000-08-15 |
2002-11-21 |
Vincent Santora |
Urea compounds and methods of uses
|
KR20040066184A
(ko)
|
2000-08-17 |
2004-07-23 |
샤단호칭키타사토겐큐쇼 |
신규 슈도에리쓰로마이신 유도체
|
DZ3398A1
(fr)
|
2000-08-31 |
2002-03-07 |
Pfizer Prod Inc |
Derives pyrazole et leur utilisation comme inhibiteurs des proteines kinases
|
US20020055117A1
(en)
|
2000-09-20 |
2002-05-09 |
James Fett |
Methods for detecting prostate cancer
|
AUPR034000A0
(en)
|
2000-09-25 |
2000-10-19 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminoalcohol derivatives
|
JP3712393B2
(ja)
|
2000-10-20 |
2005-11-02 |
エーザイ株式会社 |
含窒素芳香環誘導体
|
JP3768800B2
(ja)
|
2000-10-31 |
2006-04-19 |
キヤノン株式会社 |
画像形成装置
|
WO2002040445A1
(en)
|
2000-11-17 |
2002-05-23 |
Novo Nordisk A/S |
Glucagon antagonists/inverse agonists
|
CN1525889A
(zh)
|
2000-11-27 |
2004-09-01 |
����ˡ�A�������� |
分类物品的***、方法及程序
|
SK5862003A3
(en)
|
2000-11-28 |
2004-05-04 |
Pfizer Prod Inc |
Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents
|
EP1341771A2
(en)
|
2000-11-29 |
2003-09-10 |
Glaxo Group Limited |
Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
|
ATE392820T1
(de)
*
|
2000-12-08 |
2008-05-15 |
Kyowa Hakko Kogyo Kk |
Orale zubereitungen mit juckreizlindernder oder antipruritischer wirkung
|
DE60124594T2
(de)
|
2000-12-21 |
2007-10-04 |
Glaxo Group Ltd., Greenford |
Makrolidantibiotika
|
KR100362390B1
(ko)
|
2000-12-29 |
2002-11-23 |
삼성전자 주식회사 |
화상형성장치의 현상기-토너 카트리지 조립체
|
US7235576B1
(en)
|
2001-01-12 |
2007-06-26 |
Bayer Pharmaceuticals Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
CA2435829A1
(en)
|
2001-01-25 |
2002-08-01 |
Guilford Pharmaceuticals Inc. |
Trisubstituted carbocyclic cyclophilin binding compounds and their use
|
WO2002059081A2
(en)
|
2001-01-26 |
2002-08-01 |
Kirin Beer Kabushiki Kaisha |
Urea derivatives as inhibitors of ccr-3 receptor
|
FR2820136A1
(fr)
|
2001-01-26 |
2002-08-02 |
Aventis Pharma Sa |
Nouveaux derives de l'uree, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
|
US6670364B2
(en)
|
2001-01-31 |
2003-12-30 |
Telik, Inc. |
Antagonists of MCP-1 function and methods of use thereof
|
SI3351246T1
(sl)
|
2001-02-19 |
2019-08-30 |
Novartis Pharma Ag |
Derivat rapamicina za zdravljenje trdnega tumorja, povezanega z deregulirano angiogenezo
|
UA76977C2
(en)
|
2001-03-02 |
2006-10-16 |
Icos Corp |
Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers
|
US6525091B2
(en)
*
|
2001-03-07 |
2003-02-25 |
Telik, Inc. |
Substituted diarylureas as stimulators for Fas-mediated apoptosis
|
EP1366021B1
(en)
|
2001-03-07 |
2007-07-11 |
Telik, Inc. |
Substituted diarylureas as stimulators for fas-mediated apoptosis
|
PT1370552E
(pt)
|
2001-03-23 |
2007-04-30 |
Bayer Pharmaceuticals Corp |
Inibidores de rho-quinase
|
JP4679035B2
(ja)
|
2001-04-02 |
2011-04-27 |
ジェネンテック, インコーポレイテッド |
併用療法
|
EP1381592A1
(en)
|
2001-04-13 |
2004-01-21 |
Boehringer Ingelheim Pharmaceuticals Inc. |
1,4-disubstituted benzo-fused compounds
|
CA2490819A1
(en)
|
2001-04-13 |
2002-10-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
JP4366936B2
(ja)
|
2001-04-20 |
2009-11-18 |
バイエル コーポレイション |
キノリル、イソキノリルまたはピリジル尿素を使用するrafキナーゼの阻害
|
US7371763B2
(en)
|
2001-04-20 |
2008-05-13 |
Bayer Pharmaceuticals Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
US20030207914A1
(en)
|
2001-04-20 |
2003-11-06 |
Bayer Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
EP1461334A2
(en)
|
2001-04-27 |
2004-09-29 |
Vertex Pharmaceuticals Incorporated |
Pyrazole derived kinase inhibitors
|
JP2004530690A
(ja)
|
2001-05-16 |
2004-10-07 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
抗炎症性薬剤として有用なジアリールウレア誘導体
|
WO2003004523A1
(en)
|
2001-07-02 |
2003-01-16 |
Bayer Aktiengesellschaft |
Regulation of human citron rho/rac-interacting kinase
|
CA2453147A1
(en)
|
2001-07-11 |
2003-01-23 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Methods of treating cytokine mediated diseases
|
MEP36208A
(en)
|
2001-12-03 |
2011-02-10 |
Bayer Corp |
Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers
|
AU2002365899B2
(en)
|
2001-12-04 |
2007-09-13 |
Onyx Pharmaceuticals, Inc. |
RAF-MEK-ERK pathway inhibitors to treat cancer
|
WO2003056036A2
(en)
|
2001-12-21 |
2003-07-10 |
The Wellcome Trust |
Genes
|
US20040096855A1
(en)
|
2001-12-24 |
2004-05-20 |
Michael Stratton |
Genes
|
WO2003060111A2
(en)
|
2001-12-24 |
2003-07-24 |
Catalyst Biomedica Limited |
Cancer-specific mutants of b-raf genes and uses thereof
|
US20080108672A1
(en)
|
2002-01-11 |
2008-05-08 |
Bernd Riedl |
Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
|
US20030207872A1
(en)
|
2002-01-11 |
2003-11-06 |
Bayer Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
AU2003207961A1
(en)
|
2002-01-16 |
2003-07-30 |
Ramot At Tel Aviv University Ltd. |
Compositions and their use for enhancing and inhibiting fertilization
|
US6998391B2
(en)
|
2002-02-07 |
2006-02-14 |
Supergen.Inc. |
Method for treating diseases associated with abnormal kinase activity
|
ATE529406T1
(de)
|
2002-02-11 |
2011-11-15 |
Bayer Healthcare Llc |
Aryl-harnstoffe als kinase inhibitoren
|
EP2324825A1
(en)
|
2002-02-11 |
2011-05-25 |
Bayer Healthcare LLC |
Aryl ureas with angiogenesis inhibiting activity
|
WO2003068223A1
(en)
|
2002-02-11 |
2003-08-21 |
Bayer Corporation |
Aryl ureas with raf kinase and angiogenesis inhibiting activity
|
WO2003068229A1
(en)
|
2002-02-11 |
2003-08-21 |
Bayer Pharmaceuticals Corporation |
Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
|
US8299108B2
(en)
|
2002-03-29 |
2012-10-30 |
Novartis Ag |
Substituted benzazoles and methods of their use as inhibitors of raf kinase
|
ATE447404T1
(de)
|
2002-03-29 |
2009-11-15 |
Novartis Vaccines & Diagnostic |
Substituierte benzazole und ihre verwendung als raf-kinase-hemmer
|
DE10221524A1
(de)
|
2002-05-14 |
2003-12-04 |
Kmb Produktions Ag Felben |
Verfahren und Vorrichtung zum Herstellen von Verzehrgütern
|
US20040018528A1
(en)
|
2002-05-17 |
2004-01-29 |
Sugen, Inc. |
Novel biomarkers of tyrosine kinase inhibitor exposure and activity in mammals
|
PE20040522A1
(es)
|
2002-05-29 |
2004-09-28 |
Novartis Ag |
Derivados de diarilurea dependientes de la cinasa de proteina
|
US20060063782A1
(en)
|
2002-07-03 |
2006-03-23 |
Murray Christopher W |
3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors
|
DE60322544D1
(de)
|
2002-08-27 |
2008-09-11 |
Merck Patent Gmbh |
Glycinamid-derivate als raf-kinase-hemmer
|
CN100497302C
(zh)
|
2002-09-05 |
2009-06-10 |
神经研究公司 |
二芳基脲衍生物和它们作为氯通道阻滞剂的用途
|
WO2004037789A2
(en)
|
2002-10-24 |
2004-05-06 |
Merck Patent Gmbh |
Methylene urea derivatives as raf-kinase inhibitors
|
EP1565193B1
(en)
|
2002-11-06 |
2013-04-24 |
Dana-Farber Cancer Institute, Inc. |
Compositions for treating cancer using proteasome inhibitor PS-341
|
EP1585738A2
(en)
|
2002-11-15 |
2005-10-19 |
Novartis AG |
Drug delivery system
|
SE0203654D0
(sv)
|
2002-12-09 |
2002-12-09 |
Astrazeneca Ab |
New compounds
|
US20030232400A1
(en)
|
2002-12-20 |
2003-12-18 |
Susan Radka |
Methods of screening subjects for expression of soluble receptors of vascular endothelial growth factor (VEGF) for use in managing treatment and determining prognostic outcome
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
EP1599466B1
(en)
|
2003-02-28 |
2010-11-24 |
Bayer HealthCare LLC |
2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatrory disorders
|
EP1608639A2
(en)
|
2003-02-28 |
2005-12-28 |
Bayer Pharmaceuticals Corporation |
Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
|
US7557129B2
(en)
|
2003-02-28 |
2009-07-07 |
Bayer Healthcare Llc |
Cyanopyridine derivatives useful in the treatment of cancer and other disorders
|
EP1603879A2
(en)
|
2003-02-28 |
2005-12-14 |
Bayer Pharmaceuticals Corporation |
Substituted pyridine derivatives useful in the treatment of cancer and other disorders
|
US7531553B2
(en)
|
2003-03-21 |
2009-05-12 |
Amgen Inc. |
Heterocyclic compounds and methods of use
|
PL377124A1
(pl)
|
2003-03-24 |
2006-01-23 |
Merck Patent Gmbh |
Pochodne oksamidu użyteczne jako inhibitory kinazy raf
|
WO2004084889A1
(en)
|
2003-03-28 |
2004-10-07 |
Pfizer Inc. |
Use of protein kinase c inhibitor for suppressing sustained slow postsynaptic excitation (sspe) of enteric neurons
|
US6896863B2
(en)
|
2003-04-01 |
2005-05-24 |
E. I. Du Pont De Nemours And Company |
Sodium cyanide process
|
PT1626714E
(pt)
|
2003-05-20 |
2007-08-24 |
Bayer Pharmaceuticals Corp |
Diarilureias para doenças mediadas por pdgfr
|
BRPI0410913A
(pt)
|
2003-06-05 |
2006-06-27 |
Warner Lambert Co |
benzotiofenos substituìdos com cicloalquil e heterocicloalquil como agentes terapêuticos
|
US20040259926A1
(en)
|
2003-06-05 |
2004-12-23 |
Bruendl Michelle M. |
3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
|
WO2005002673A1
(en)
|
2003-07-03 |
2005-01-13 |
Astex Therapeutics Limited |
Raf kinase inhibitors
|
JP4750701B2
(ja)
|
2003-07-07 |
2011-08-17 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
マロンアミド誘導体
|
MXPA06000117A
(es)
|
2003-07-08 |
2006-04-27 |
Novartis Ag |
Uso de rapamicina y derivados de rapamicina para el tratamiento de perdida osea.
|
CA2531859C
(en)
|
2003-07-11 |
2013-08-06 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Benzimidazole derivatives as raf kinase inhibitors
|
US7691870B2
(en)
|
2003-07-11 |
2010-04-06 |
Merck Patent Gmbh |
Benzimidazole carboxamides as raf kinase inhibitors
|
WO2005016252A2
(en)
|
2003-07-11 |
2005-02-24 |
Ariad Gene Therapeutics, Inc. |
Phosphorus-containing macrocycles
|
WO2005009367A2
(en)
|
2003-07-17 |
2005-02-03 |
Ambit Biosciences Corporation |
Treatment of diseases with kinase inhibitors
|
SI1663978T1
(sl)
|
2003-07-23 |
2008-02-29 |
Bayer Pharmaceuticals Corp |
Fluoro substituirana omega-karboksiaril difenil secnina za zdravljenje ali preprecevanje bolezni instanj
|
WO2006125540A1
(en)
|
2005-05-27 |
2006-11-30 |
Bayer Healthcare Ag |
Combination therapy comprising a diaryl urea compound and a pi3, akt kinase or mtor inhibitors (rapamycins) for cancer treatment
|
TW200523262A
(en)
|
2003-07-29 |
2005-07-16 |
Smithkline Beecham Corp |
Inhibitors of AKT activity
|
DE10334663A1
(de)
|
2003-07-30 |
2005-03-10 |
Merck Patent Gmbh |
Harnstoffderivate
|
WO2005016126A2
(en)
*
|
2003-08-15 |
2005-02-24 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Multifactorial assay for cancer detection
|
BRPI0414698A
(pt)
|
2003-09-23 |
2006-11-28 |
Novartis Ag |
combinação de um inibidor receptor de vegf com um agente quimioterapêutico
|
DE10344223A1
(de)
|
2003-09-24 |
2005-04-21 |
Merck Patent Gmbh |
1,3-Benzoxazolylderivate als Kinase-Inhibitoren
|
EP1678123A1
(en)
*
|
2003-10-15 |
2006-07-12 |
Bayer HealthCare AG |
Tetrahydro-naphthalene and urea derivatives
|
AU2004281154A1
(en)
|
2003-10-16 |
2005-04-28 |
Novartis Vaccines And Diagnostics, Inc. |
2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines as inhibitors of Raf kinase for treatment of cancer
|
JP4755991B2
(ja)
|
2003-10-16 |
2011-08-24 |
ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド |
Rafキナーゼインヒビターとしての置換ベンゾアゾールおよびその使用
|
DE10349587A1
(de)
|
2003-10-24 |
2005-05-25 |
Merck Patent Gmbh |
Benzimidazolylderivate
|
DE10352979A1
(de)
|
2003-11-13 |
2005-06-09 |
Merck Patent Gmbh |
Pyridopyrimidinone
|
US20050148605A1
(en)
|
2003-11-13 |
2005-07-07 |
Ambit Biosciences Corporation |
Amide derivatives as ABL modulators
|
DE10354060A1
(de)
|
2003-11-19 |
2005-06-02 |
Merck Patent Gmbh |
Pyrrolderivate
|
AU2004296376B2
(en)
|
2003-12-05 |
2010-03-04 |
Bristol-Myers Squibb Company |
Inhibitors of type 2 vascular endothelial growth factor receptors
|
WO2005056014A1
(en)
|
2003-12-09 |
2005-06-23 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Methods for suppressing an immune response or a treating a proliferative disorder
|
EP1692110A1
(en)
|
2003-12-10 |
2006-08-23 |
MERCK PATENT GmbH |
Diacylhydrazine derivatives
|
US20070134670A1
(en)
|
2003-12-12 |
2007-06-14 |
Bayer Pharmaceuticals Corporation |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
WO2005075425A2
(en)
|
2004-01-30 |
2005-08-18 |
Merck Patent Gmbh |
Substituted bisarylurea derivatives as kinase inhibitors
|
JP2007530453A
(ja)
|
2004-03-19 |
2007-11-01 |
ザ ペン ステート リサーチ ファウンデーション |
黒色腫を治療するためのコンビナトリアル法および組成物
|
ATE517885T1
(de)
|
2004-04-30 |
2011-08-15 |
Bayer Healthcare Llc |
Substituierte pyrazolyl-harnstoff-derivate zur behandlung von krebs
|
CA2578442A1
(en)
|
2004-08-27 |
2006-03-09 |
Bayer Pharmaceuticals Corporation |
Pharmaceutical compositions comprising 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-phenoxy}-pyridine-2-carboxylic acid methyl amide for the treatment of cancer
|
MY191349A
(en)
*
|
2004-08-27 |
2022-06-17 |
Bayer Pharmaceuticals Corp |
New pharmaceutical compositions for the treatment of hyper-proliferative disorders
|
AU2005281704A1
(en)
|
2004-09-06 |
2006-03-16 |
Nycomed Gmbh |
Novel pyrazolopyrimidines
|
DK1797038T3
(da)
|
2004-09-29 |
2012-09-03 |
Bayer Pharma AG |
Termodynamisk stabil form af bay 43-9006-tosylat
|
US8124782B2
(en)
|
2004-09-29 |
2012-02-28 |
Bayer Pharma Aktiengesellschaft |
Process for the preparation of 4-{4-[({[4 chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide
|
ES2465469T3
(es)
|
2005-01-14 |
2014-06-05 |
Gilead Connecticut, Inc. |
Diaril ureas 1,3-sustituidas como moduladores de la actividad quinasa
|
CA2601955C
(en)
|
2005-03-07 |
2012-07-10 |
Bayer Healthcare Ag |
Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
|
DE102005015253A1
(de)
|
2005-04-04 |
2006-10-05 |
Merck Patent Gmbh |
Pyrazolderivate
|
JP2008545670A
(ja)
|
2005-05-27 |
2008-12-18 |
バイエル・ヘルスケア・アクチェンゲゼルシャフト |
疾患を処置するためのジアリールウレア類を含む組合せ治療
|
EP1937837A2
(en)
|
2005-07-29 |
2008-07-02 |
Siemens Healthcare Diagnostics Inc. |
Methods and kits for the prediction of therapeutic success, recurrence free and overall survival in cancer therapies
|
ATE493652T1
(de)
*
|
2005-08-11 |
2011-01-15 |
Siemens Healthcare Diagnostics |
Quantitative assays für pdgfr-beta- in körperflüssigkeiten
|
US20070066060A1
(en)
|
2005-09-19 |
2007-03-22 |
Taiwan Semiconductor Manufacturing Co., Ltd. |
Semiconductor devices and fabrication methods thereof
|
RS52383B
(en)
|
2005-09-21 |
2012-12-31 |
4Sc Ag |
NEW SULFONYLPYROLS AS HDAC INHIBITORS
|
JP5305909B2
(ja)
|
2005-09-21 |
2013-10-02 |
フォーエスシー アクチエンゲゼルシャフト |
ヒストンデアセチラーゼインヒビターとしてのスルホニルピロール塩酸塩
|
BRPI0617488A2
(pt)
|
2005-10-21 |
2011-07-26 |
Bayer Healthcare Llc |
mÉtodo para a monitoraÇço do estado de uma doenÇa associada a uma via de vegf-165 ativada por ultra-expressço ou por mutaÇço de proteÍna vegf-165 em um paciente, mÉtodo de seleÇço de terapia para um paciente humano com uma doenÇa e mÉtodo de dignàstico para detectar uma doenÇa associada a uma via de vegf-165 ativada por ultra-expressço ou por mutaÇço de proteÍna vegf-165 em um paciente
|
US20090215835A1
(en)
|
2005-10-31 |
2009-08-27 |
Scott Wilhelm |
Treatment of cancer with sorafenib
|
CA2627875A1
(en)
*
|
2005-10-31 |
2007-05-10 |
Bayer Pharmaceuticals Corporation |
Combinations comprising sorafenib and interferon for the treatment of cancer
|
US8329408B2
(en)
|
2005-10-31 |
2012-12-11 |
Bayer Healthcare Llc |
Methods for prognosis and monitoring cancer therapy
|
KR20080073729A
(ko)
|
2005-11-02 |
2008-08-11 |
바이엘 헬스케어 엘엘씨 |
암의 예측 및 예후 방법, 및 암 치료 모니터링 방법
|
BRPI0618564A2
(pt)
|
2005-11-02 |
2011-09-06 |
Bayer Healthcare Llc |
métodos para predição e prognóstico de cáncer e para monitoração de terapia contra cáncer
|
MY144860A
(en)
|
2005-11-10 |
2011-11-30 |
Bayer Schering Pharma Ag |
Diaryl ureas for treating pulmonary hypertension
|
US20100035888A1
(en)
|
2005-11-10 |
2010-02-11 |
Bater Healthcare AG |
Diaryl Urea for Treating Pulmonary Hypertension
|
WO2007059094A2
(en)
|
2005-11-14 |
2007-05-24 |
Bayer Healthcare Llc |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
WO2007059154A2
(en)
|
2005-11-14 |
2007-05-24 |
Bayer Healthcare Llc |
Treatment of cancers with acquired resistance to kit inhibitors
|
WO2007059155A1
(en)
|
2005-11-14 |
2007-05-24 |
Bayer Pharmaceuticals Corporation |
Treatment of cancers having resistance to chemotherapeutic agents
|
WO2007064872A2
(en)
|
2005-12-01 |
2007-06-07 |
Bayer Healthcare Llc |
Urea compounds useful in the treatment of cancer
|
US20090227637A1
(en)
|
2005-12-15 |
2009-09-10 |
Olaf Weber |
Diaryl ureas for treating virus infections
|
WO2007087575A2
(en)
|
2006-01-24 |
2007-08-02 |
University Of Chicago |
Compositions and methods for treating pulmonary hypertension
|
CN101389629A
(zh)
|
2006-02-22 |
2009-03-18 |
4Sc股份公司 |
作为eg5驱动蛋白调节剂的吲哚吡啶
|
CA2643488C
(en)
|
2006-02-22 |
2014-08-05 |
4Sc Ag |
Indolopyridines as eg5 kinesin modulators
|
WO2007109571A2
(en)
|
2006-03-17 |
2007-09-27 |
Prometheus Laboratories, Inc. |
Methods of predicting and monitoring tyrosine kinase inhibitor therapy
|
JP2009532029A
(ja)
|
2006-03-31 |
2009-09-10 |
バイエル・ヘルスケア・エルエルシー |
癌の予報および予後方法および癌治療のモニタリング
|
WO2007139930A2
(en)
|
2006-05-26 |
2007-12-06 |
Bayer Healthcare Llc |
Drug combinations with substituted diaryl ureas for the treatment of cancer
|
WO2008055966A1
(en)
|
2006-11-09 |
2008-05-15 |
Abbott Gmbh & Co. Kg |
Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
|
WO2008079968A1
(en)
|
2006-12-20 |
2008-07-03 |
Bayer Healthcare Llc |
4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl) phenyl]-1h-pyrazol-5-yl } carbamoyl)-amino] -3-fluorophenoxy} -n-methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cancer
|
JP2010514692A
(ja)
|
2006-12-20 |
2010-05-06 |
バイエル ヘルスケア リミティド ライアビリティ カンパニー |
癌の治療に有用なヒドロキシメチルフェニルピラゾリル尿素化合物
|
US8680124B2
(en)
|
2007-01-19 |
2014-03-25 |
Bayer Healthcare Llc |
Treatment of cancers with acquired resistance to kit inhibitors
|
NZ583790A
(en)
|
2007-09-10 |
2012-04-27 |
Cipla Ltd |
Process for the preparation the raf kinase inhibitor sorafenib and intermediates for use in the process
|
WO2009054004A2
(en)
|
2007-10-22 |
2009-04-30 |
Natco Pharma Limited |
Process for the preparation of sorafenib
|
JP5753785B2
(ja)
|
2008-11-07 |
2015-07-22 |
ノバベイ・ファーマシューティカルズ・インコーポレイテッドNovabay Pharmaceuticals,Inc. |
抗菌オキサゾリジノン、ヒダントインおよびイミダゾリジノン組成物
|
CN102111718B
(zh)
|
2009-12-28 |
2014-12-17 |
深圳市齐创美科技有限公司 |
电子信息分发***及方法
|
JP5821626B2
(ja)
|
2011-12-27 |
2015-11-24 |
富士ゼロックス株式会社 |
画像形成装置及びプログラム
|